ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

174
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
bullishFujitec Co Ltd
10 Nov 2024 08:10

Weekly Deals Digest (10 Nov) - Fujitec, I-PEX, NEC Networks, Net One, LAC, Get Nice, Swiggy

Last week, notable developments occurred in Event-Driven (Fujitec, I-PEX, NEC Networks, Net One, LAC, Get Nice) and ECM (Swiggy).

Logo
310 Views
Share
04 Nov 2024 19:44

HK Merger Arb: Evaluating the Post China TCM Widening Spreads

The gross spreads of large HK merger arb situations have increased since 18 October, the China TCM deal break date. We assess the spreads of HK's...

Logo
533 Views
Share
04 Nov 2024 01:13

Merger Arb Mondays (04 Nov) - Haitong, Canvest, Capital Grand, Capitol, Fuji Soft, NESIC, Elematec

This week, the highest gross spreads are Seven & I (28.8%), Capital Grand (18.1%), Henlius (13.1%), Canvest (12.4%), GA Pack (10.0%), Shinko...

Logo
342 Views
Share
bullishFosun Tourism
16 Dec 2024 08:55

Fosun Tourism (1992.HK) Privatization - The Cancellation Price Is Not Good Enough

​Fosun Tourism is on the rise after overcoming difficulties, with potential for share price to return to IPO level. Even if the Offer Price is...

Logo
345 Views
Share
01 Nov 2024 06:55

(Mostly) Asia M&A, Oct 2024: Arcadium, T Gaia, Elematec, NEC Network, MPHB, Sigma Health, Fuji Soft

For the month of Oct, 10 new deals were discussed on Smartkarma with an overall deal size of just ~US$9bn. The average premium for the new deals...

Logo
223 Views
Share
x